about
Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data.Ryanodine receptor-mediated calcium leak drives progressive development of an atrial fibrillation substrate in a transgenic mouse model.Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction: a complex relationship.The effect of bone marrow mononuclear stem cell therapy on left ventricular function and myocardial perfusion.Worsening renal function is not associated with response to treatment in acute heart failure.Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction.Inhibition of CaMKII phosphorylation of RyR2 prevents inducible ventricular arrhythmias in mice with Duchenne muscular dystrophy.Atrial identity is determined by a COUP-TFII regulatory network.Alterations in ryanodine receptors and related proteins in heart failureMutation E169K in junctophilin-2 causes atrial fibrillation due to impaired RyR2 stabilization.Comparison of three commercially available softwares for measuring left ventricular perfusion and function by gated SPECT myocardial perfusion imaging.Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions.New insights into mechanisms of action of carvedilol treatment in chronic heart failure patients--a matter of time for contractility.Improved propensity matching for heart failure using neural gas and self-organizing mapsUnsupervised cluster analysis and mortality risk in the Digitalis Investigation Group (DIG) trial of heart failureRecurrent low-level troponin I elevation is a worse prognostic indicator than occasional injury pattern in patients hospitalized with heart failure
P50
Q33578694-36B28D13-C7BE-4D9B-B67F-68522F801D17Q33631895-8AD67F8A-8717-4BD2-AA8F-568BB9BA0E0EQ34777591-319C8182-3902-4FCD-9276-30835A6539B8Q35079018-188EDA37-BB82-4A65-B245-016284A62918Q36381074-5405A955-D693-4995-90A0-E81E7B74E292Q36393927-CE19E730-8688-4BE5-ADB2-93C24280443EQ36707428-3941E546-3046-4811-9660-E19CDDB4CF34Q36942935-82A7F3CC-8F4A-4194-974D-FC04888B68B4Q37239340-1FFFE5BE-76DB-4396-9D02-526B3CFD6BE9Q37315854-EEA206D4-75B5-4CE2-A0A0-E3A2615CB613Q43899878-5449CF5A-F662-426A-B65E-76E38FD74292Q44747863-6F7B421B-A0DC-4402-B253-4E042CF9FDE5Q48720009-B3E4D476-DECB-4CAB-9D98-70D1E96BC2B4Q59192107-1D090374-05FE-4041-B3AF-E747DEEE1656Q59192111-96C1D479-A68F-4945-AF3D-D5A1D2B4F107Q82688373-00C36101-BCD7-46CD-8E1B-2032E28370FD
P50
description
researcher ORCID ID = 0000-0002-5579-0658
@en
wetenschapper
@nl
name
Sameer Ather
@ast
Sameer Ather
@en
Sameer Ather
@es
Sameer Ather
@nl
type
label
Sameer Ather
@ast
Sameer Ather
@en
Sameer Ather
@es
Sameer Ather
@nl
prefLabel
Sameer Ather
@ast
Sameer Ather
@en
Sameer Ather
@es
Sameer Ather
@nl
P1153
6602272929
P31
P496
0000-0002-5579-0658